Document:

Exhibit 10.2

 

LEAK-OUT AGREEMENT

 

November __, 2018

 

This agreement (the
“Leak-Out Agreement”) is being delivered to you in connection with an understanding by and among DelMar Pharmaceuticals,
Inc., a Nevada corporation (the “Company”), and the person or persons named on the signature pages hereto (collectively,
the “Holder”).

 

Reference is hereby
made to (a) the Warrant Exercise and Exchange Agreement, dated November __, 2018, by and among the Company, the Holder and other
parties thereto (the “Warrant Agreement”), pursuant to which the Holder exercised certain Warrants to purchase
shares of Common Stock and exchanged Warrants for shares of the Common Stock (collectively, the “Shares”). Capitalized
terms not defined herein shall have the meaning as set forth in the Warrant Agreement.

 

The Holder agrees solely
with the Company that from the date that both the undersigned executes the Warrant Agreement and the Company or its agent has notified
the Holder that each other holder of the Warrants (each, an “Other Holder”) executes an agreement (collectively,
the “Other Leak-Out Agreements”) regarding such Other Holder’s trading with terms that are no less restrictive
than the terms contained herein (such date, the “Effective Date”) and ending at 4:00 pm (New York City time)
on January ___, 2019 (such period, the “Restricted Period”), neither the Holder, nor any Affiliate of such Holder
which (x) had or has knowledge of the transactions contemplated by the Warrant Agreement, (y) has or shares discretion relating
to such Holder’s investments or trading or information concerning such Holder’s investments, including in respect of
the Shares, or (z) is subject to such Holder’s review or input concerning such Affiliate’s investments or trading (together,
the “Holder’s Trading Affiliates”), collectively, shall sell dispose or otherwise transfer, directly or
indirectly, (including, without limitation, any sales, short sales, swaps or any derivative transactions that would be equivalent
to any sales or short positions) on any Trading Day during the Restricted Period (any such date, a “Date of Determination”),
the Shares, in an amount more than ___% of the trading volume of Common Stock as reported by Bloomberg, LP for the applicable Date
of Determination; provided, that the foregoing restriction shall not apply to any sales by the Holder or any of the Holder’s
Trading Affiliates at a price greater than $1.25 (in each case, as adjusted for stock splits, stock dividends, stock combinations,
recapitalizations or other similar events occurring after the date hereof).

 

Notwithstanding anything
herein to the contrary, during the Restricted Period, the Holder may, directly or indirectly, sell or transfer all, or any part,
of the Shares to any Person (an “Assignee”) in a transaction which does not need to be reported on the Nasdaq
consolidated tape, without complying with (or otherwise limited by) the restrictions set forth in this Leak-Out Agreement; provided,
that as a condition to any such sale or transfer an authorized signatory of the Company and such Assignee duly execute and deliver
a leak-out agreement in the form of this Leak-Out Agreement (an “Assignee Agreement”, and each such transfer
a “Permitted Transfer”) and, subsequent to a Permitted Transfer, sales of the Holder and the Holder’s
Trading Affiliates and all Assignees (other than any such sales that constitute Permitted Transfers) shall be aggregated for all
purposes of this Leak-Out Agreement and all Assignee Agreements.

 

    	 	1	 

     

    

 

Any notices, consents,
waivers or other communications required or permitted to be given under the terms of this Leak-Out Agreement must be in writing
and shall be given in accordance with the terms of the Warrant Agreement.

 

This Leak-Out Agreement
constitutes the entire agreement among the parties hereto with respect to the subject matter hereof and supersedes all prior negotiations,
letters and understandings relating to the subject matter hereof and are fully binding on the parties hereto.

 

This Leak-Out Agreement
may be executed simultaneously in any number of counterparts. Each counterpart shall be deemed to be an original, and all such
counterparts shall constitute one and the same instrument. This Leak-Out Agreement may be executed and accepted by facsimile or
PDF signature and any such signature shall be of the same force and effect as an original signature.

 

The terms of this Leak-Out
Agreement shall be binding upon and shall inure to the benefit of each of the parties hereto and their respective successors and
assigns.

 

This Leak-Out Agreement
may not be amended or modified except in writing signed by each of the parties hereto.

 

All questions concerning
the construction, validity, enforcement and interpretation of this Leak-Out Agreement shall be governed by Article IV of the Warrant
Agreement.

 

Each party hereto acknowledges
that, in view of the uniqueness of the transactions contemplated by this Leak-Out Agreement, the other party or parties hereto
may not have an adequate remedy at law for money damages in the event that this Leak-Out Agreement has not been performed in accordance
with its terms, and therefore agrees that such other party or parties shall be entitled to seek specific enforcement of the terms
hereof in addition to any other remedy it may seek, at law or in equity.

 

    	 	2	 

     

    

 

The obligations of
the Holder under this Leak-Out Agreement are several and not joint with the obligations of any Other Holder, and the Holder shall
not be responsible in any way for the performance of the obligations of any Other Holder under any such other agreement. Nothing
contained herein or in this Leak-Out Agreement, and no action taken by the Holder pursuant hereto, shall be deemed to constitute
the Holder and Other Holders as a partnership, an association, a joint venture or any other kind of entity, or create a presumption
that the Holder and the Other Holders are in any way acting in concert or as a group with respect to such obligations or the transactions
contemplated by this Leak-Out Agreement and the Company acknowledges that the Holder and the Other Holders are not acting in concert
or as a group with respect to such obligations or the transactions contemplated by this Leak-Out Agreement or any other agreement.
The Company and the Holder confirm that the Holder has independently participated in the negotiation of the transactions contemplated
hereby with the advice of its own counsel and advisors. The Holder shall be entitled to independently protect and enforce its rights,
including, without limitation, the rights arising out of this Leak-Out Agreement, and it shall not be necessary for any Other Holder
to be joined as an additional party in any proceeding for such purpose.

 

The Company hereby
represents and warrants as of the date hereof and covenants and agrees from and after the date hereof that it will enforce the
provisions of each Other Leak-Out Agreement in accordance with its terms. If any party to any Other Leak-Out Agreement breaches
any provision of such Other Leak-Out Agreement, the Company shall promptly use its reasonable best efforts to seek specific performance
of the terms of such Other Leak-Out Agreement.

 

The Company hereby
represents and warrants as of the date hereof and covenants and agrees from and after the date hereof that none of the terms offered
to any Other Holder with respect to any Other Leak-Out Agreement (or any amendment, modification, waiver or release thereof) (each
a “Settlement Document”), is or will be more favorable to such Other Holder than those of the Holder and this
Leak-Out Agreement. If, and whenever on or after the date hereof, the Company enters into a Settlement Document, then (i) the Company
shall provide notice thereof to the Holder promptly following the occurrence thereof and (ii) the terms and conditions of this
Other Leak-Out Agreement shall be, without any further action by the Holder or the Company, automatically amended and modified
in an economically and legally equivalent manner such that the Holder shall receive the benefit of the more favorable terms and/or
conditions (as the case may be) set forth in such Settlement Document, provided that upon written notice to the Company at any
time the Holder may elect not to accept the benefit of any such amended or modified term or condition, in which event the term
or condition contained in this Leak-Out Agreement shall apply to the Holder as it was in effect immediately prior to such amendment
or modification as if such amendment or modification never occurred with respect to the Holder. The provisions of this paragraph
shall apply similarly and equally to each Settlement Document.

 

[The remainder of the page is intentionally
left blank]

 

    	 	3	 

     

    

 

[Signature Page to DMPI Leak-out]

 

	 	Sincerely,
	 	 
	 	DELMAR PHARMACEUTICALS, INC.
	 	 	 
	 	By: 	                                        
	 	 	Name:
	 	 	Title:

 

	Agreed to and Acknowledged:	 
	 	 
	“HOLDER”	 
	 	 
	 	 
	 	 
	By: 	                                        	 
	 	Name:	 
	 	Title: 	 

 

    	 	4Exhibit 10.1

 

Shanghai TCH Energy Technology Co., Ltd.
and Jihua Wang

Agreement of Supplementary and Amendment
to the Equity Purchase Agreement 

 

This Agreement of Supplementary and Amendment
is signed on November 21, 2018 in Xi’an by two parties below.

 

Party
A: Shanghai TCH Energy Technology Co., Ltd. (“Party A”)

 

Legal Representative: Geyun Wang

 

Address: No. 88 Century Avenue,
Pudong New District, Shanghai

 

Party
B: Jihua Wang

 

Address:
Yanta District, Xi’an

 

All terms in this Agreement of Supplementary and Amendment,
unless otherwise specified, are defined in the Equity Purchase Agreement entered by the Party A and Party B on September 30, 2018
(hereinafter referred to as the “Original Agreement”).

 

Whereas:

 

		(1)	The parties signed an Equity Purchase Agreement on September 30, 2018.

 

		(2)	The parties need to make supplementary agreements on matters not specified in the Equity Purchase
Agreement.

 

		(3)	The parties have negotiated and reached new agreements on the transferred asset, transaction price
and payment method in consideration of the issues encountered by both parties in the process of implementing the Equity Purchase
Agreement.

 

According to the “Company Law of the People’s Republic
of China”, the “Contract Law of the People’s Republic of China”, the “Regulations of Administration Measures
for Material Assets Reorganization of Non-listed Public Company”, based on the principle of equality and voluntariness, after
friendly negotiation, the two parties agree to revise certain parts of the Original Agreement and have reached the following supplementary
amendment agreements:

 

Article I Transferred Asset,
Transaction Price and Payment Method

 

		1.	The Transferred Asset of the transaction in Article 2.1 of the Original Agreement shall be revised from “20% equity ownership
of Target Company owned by Party B” to “18% equity ownership of Target Company owned by Party B”;

 

     

     

    

 

		2.	The Transaction Price of Transferred Asset in Article 2.2 of the Original Agreement shall be revised from “RMB 320 million”
to “RMB 288 million”.

 

		3.	The shares payment in Article 2.3.1 of the Original Agreement shall be revised from “RMB 260 million” to “RMB
228 million”; The issuance price for both common stock and preferred shares of CREG shall be revised from “$1.90 per
share” to “$1.70 per share”; The number of preferred shares to be issued to Party B shall be revised from “17,376,950
shares” to “16,837,340 shares”.

 

Article II If any activities of the Target Company
before the equity transfer result in the administrative actions, judicial proceedings or penalties which cause the Target Company
unable to conduct its normal operation after the transfer of the equity, Party B shall reimburse all the Transaction Price to Party
A.

 

Article III Party B shall assist Party A to complete
the equity transfer and registration change of Target Company. If the Original Agreement or this Agreement of Supplementary and
Amendment are invalid due to the reasons of Party B or Target Company, Party B shall assume all the responsibilities and compensate
Party A for its losses.

 

Article IV Party B warrants that its equity of Target
Company does not have any defect of rights. If there is any loss caused to Party A or the Target Company due to the defect of the
Transferred Asset of Party B, Party B shall be liable for compensation.

 

Article V If there is any inconsistency between the
Original Agreement and this Agreement of Supplementary and Amendment, this Agreement shall prevail.

 

Article VI This Agreement of Supplementary and Amendment
shall become effective after being signed and sealed by both parties. The applicable law and dispute resolution of this Agreement
shall be the same as the Original Agreement.

 

Article VII When this Agreement becomes effective,
it shall become an integral part of the Original Agreement and shall have the same legal effect as the Original Agreement. . Except
for the contents that are expressly revised in this Agreement, all terms of the Original Agreement remain in full force and effect.

 

Article VIII This Agreement is made in fourteen counterparts,
each party shall hold two counterparts, and the remaining copies shall be reserved for the purpose of reporting to the approval
and registration authorities related to this transaction, each of which shall have the same legal effect.

 

Party A: Shanghai TCH Energy Technology
Co., Ltd.

 

	Legal Representative/Authorized Representative: 	/s/ Geyun Wang	 

 

Party B: Jihua Wang

 

	Authorized Representative: 	/s/ Jihua Wang

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00289-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00289-of-00352.parquet"}]]